Oracle Delivers Foundation for More Intelligent Healthcare

Go back to Oracle Delivers Foundation for More Intelligent Healthcare

Argus Upgrades Oracle (ORCL) to Buy

March 14, 2024 7:38 AM EDT

Argus analyst Joseph Bonner upgraded Oracle (NYSE: ORCL) from Hold to Buy with a price target of $145.00.

The analyst comments "Management sees revenue acceleration into FY25. Oracle reported a 16% increase in non-GAAP EPS on 7% revenue growth in fiscal. We are raising Our... More

Oracle (ORCL) PT Raised to $142 at CFRA

March 12, 2024 9:30 AM EDT

CFRA analyst Angelo Zino raised the price target on Oracle (NYSE: ORCL) to $142.00 (from $130.00) while maintaining a Hold rating.

The analyst comments "We increase our 12-month target to $142 from $130, on a higher revised P/E of 21x our CY 25 EPS estimate of... More